From 1998 to 2001, prescription costs in the United States and England improved by 62 percent and 30 percent respectively. Yet, because the 1970s, many developing countries possess create national lists of essential medicines, which try to increase usage of medicines, promote better health and contain costs. Related StoriesWhy perform we rest? An interview with Professor WisdenDiabetic retinopathy therapy innovations: an interview with Richard Kirk, CEO of PolyphotonixExpanded use for IntelliCap with additional CE Mark for aspiration of fluidsCould the fundamental drugs concept help rich countries to control the rise in medication costs? Confronted with these spiralling costs and increasing demands for quality health care by ageing populations, industrialised countries would do well to consider and adopt these methods, writes Hans Hogerzeil of the global world Wellness Organization.ADNI Principal Investigator Michael Weiner, M.D., director of the Center for the Imaging of Neurodegenerative Illnesses at the SAN FRANCISCO BAY AREA VA Medical Center and professor of radiology, medicine, psychiatry, and neurology at the University of California, SAN FRANCISCO BAY AREA, said, The launch of this genetics data, in conjunction with the scientific, cognitive, MRI, PET, and blood/cerebrospinal liquid data in the ADNI database already, will right now allow investigators to explore genetic factors related to the rate of progression of Alzheimer’s disease.